Skip to content

Clinical study of 18F-PSMA PET/CT in radiotherapy of adenoid cystic carcinoma of head and neck

Clinical study of 18F-PSMA PET/CT in radiotherapy of adenoid cystic carcinoma of head and neck

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600127285
Enrollment
Unknown
Registered
2026-06-29
Start date
2024-04-24
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenoid cystic carcinoma of the head and neck

Interventions

Gold Standard:Surgical or biopsy pathology.
Index test:The optimal SUV threshold for PSMA diagnosis of adenoid cystic carcinoma.

Sponsors

Shanghai Proton and Heavy Ion Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Sign the informed consent form; 2.Age = 18 years old; 3.People with the ability to comply with the plan; 4.Patients with pathologically confirmed adenoid cystic carcinoma; 5.Those who can cooperate and successfully complete the examination process during PET/CT examination;

Exclusion criteria

Exclusion criteria: 1.Patients with previous history of other head and neck malignancies (except thyroid cancer); 2.Those who have undergone radiotherapy and chemotherapy for the head and neck region; 3.Not sign the informed consent form; 4.Patients who fail to complete PET/CT examinations; 5.Clinical researcher who withdrew midway; 6.Woman of childbearing age has a positive pregnancy test;

Design outcomes

Primary

MeasureTime frame
SUV;Diagnostic performance: sensitivity and specificity;

Countries

China

Contacts

Public ContactHu Chaosu, Cheng Jingyi

Shanghai Proton and Heavy Ion Hospital

jingyi.cheng@sphic.org.cn+86 21 3829 6666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026